| Purpose(s) of test, No (%)a,b | Academic/Hospital (N = 6312) | Company (N = 13437) | Institute/Center (N = 2634) | Other (N = 1616) |
|---|---|---|---|---|
| Diagnosis | 6122 (97.0) | 13055 (97.2) | 2631 (99.9) | 1466 (90.7) |
| Drug Response | 63 (1.0) | 61 (0.5) | 11 (0.4) | 12 (0.7) |
| Monitoring | 360 (5.7) | 18 (0.1) | 5 (0.2) | 1 (0.1) |
| Mutation Confirmation | 4418 (70.0) | 5260 (39.1) | 855 (32.5) | 586 (36.3) |
| Pre-implantation diagnosis | 103 (1.6) | 7 (0.1) | 23 (0.9) | 18 (1.1) |
| Pre-symptomatic | 2828 (44.8) | 2083 (15.5) | 98 (3.7) | 345 (21.3) |
| Predictive | 29 (0.5) | 530 (3.9) | 10 (0.4) | 40 (2.5) |
| Prognostic | 93 (1.5) | 37 (0.3) | 12 (0.5) | 4 (0.2) |
| Recurrence | 5 (0.1) | 5 (0.0) | 1 (0.0) | 18 (1.1) |
| Risk Assessment | 3343 (53.0) | 1637 (12.2) | 528 (20.0) | 160 (9.9) |
| Screening | 2138 (33.9) | 2010 (15.0) | 415 (15.8) | 178 (11.0) |
| Therapeutic Management | 18 (0.3) | 126 (0.9) | 8 (0.3) | 2 (0.1) |